Adagene Correlations
| ADAG Stock | USD 2.75 0.10 3.77% |
The correlation of Adagene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adagene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adagene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Good diversification
The correlation between Adagene and NYA is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and NYA in the same portfolio, assuming nothing else is changed.
Adagene |
The ability to find closely correlated positions to Adagene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adagene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adagene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adagene to buy it.
Moving against Adagene Stock
| 0.69 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.66 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.63 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.53 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.53 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.47 | OGI | OrganiGram Holdings Fiscal Year End 17th of December 2024 | PairCorr |
| 0.43 | ELYM | Eliem Therapeutics | PairCorr |
| 0.41 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.67 | ACRV | Acrivon Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.61 | OCEA | Ocean Biomedical | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Adagene Stock performing well and Adagene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adagene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AVTE | 4.29 | 0.11 | 0.05 | 0.13 | 4.93 | 11.11 | 28.53 | |||
| ACRV | 6.42 | 1.58 | 0.26 | 1.28 | 4.91 | 17.65 | 73.69 | |||
| RZLT | 4.97 | 1.71 | 0.27 | 1.83 | 5.25 | 12.17 | 21.05 | |||
| ANTX | 4.72 | (2.21) | 0.00 | (1.19) | 0.00 | 3.78 | 77.96 | |||
| ANEB | 2.62 | 0.28 | 0.04 | (0.51) | 3.50 | 6.20 | 20.75 | |||
| ANAB | 2.63 | (0.40) | 0.00 | (0.13) | 0.00 | 5.89 | 22.98 | |||
| MLYS | 2.93 | 0.26 | 0.12 | 0.19 | 3.12 | 6.29 | 26.82 | |||
| ELYM | 3.70 | 0.80 | 0.16 | (0.75) | 3.04 | 4.17 | 79.43 | |||
| JANX | 8.95 | 4.20 | 1.06 | 2.00 | 2.75 | 12.06 | 240.08 | |||
| PMVP | 3.01 | 0.16 | 0.04 | 0.23 | 3.64 | 7.45 | 21.67 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Adagene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Adagene Corporate Management
Elected by the shareholders, the Adagene's board of directors comprises two types of representatives: Adagene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adagene. The board's role is to monitor Adagene's management team and ensure that shareholders' interests are well served. Adagene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adagene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alexander Goergen | VP Development | Profile | |
| Guizhong Liu | Head Pharmacology | Profile | |
| Xiaohong She | Senior Operations | Profile | |
| Ling Zhou | Head Resources | Profile | |
| Man MBA | CFO Director | Profile | |
| Qinghai Zhao | Chief Officer | Profile | |
| Fangyong Du | Chief Officer | Profile |
Already Invested in Adagene?
The danger of trading Adagene is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Adagene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Adagene. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Adagene is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.Note that the Adagene information on this page should be used as a complementary analysis to other Adagene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Adagene Stock analysis
When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Adagene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.44) | Revenue Per Share 0.414 | Quarterly Revenue Growth (0.85) | Return On Assets (0.11) | Return On Equity (0.25) |
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.